• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.微小RNA-147通过抑制HOXC6抑制人肝癌细胞的增殖、迁移和化疗敏感性。
Am J Cancer Res. 2016 Dec 1;6(12):2787-2798. eCollection 2016.
2
[The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].[微小RNA-7对肝癌HepG2细胞增殖和侵袭的影响]
Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):406-411. doi: 10.3760/cma.j.issn.0253-3766.2018.06.002.
3
[LncRNA HULC promots HCC growth by downregulating miR-29].[长链非编码RNA HULC通过下调miR-29促进肝癌生长]
Zhonghua Zhong Liu Za Zhi. 2019 Sep 23;41(9):659-666. doi: 10.3760/cma.j.issn.0253-3766.2019.09.004.
4
Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.miR-218的过表达通过RET抑制肝癌细胞生长。
Tumour Biol. 2015 Mar;36(3):1511-8. doi: 10.1007/s13277-014-2679-1. Epub 2014 Nov 6.
5
MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.微小RNA-15a-5p通过靶向脑源性神经营养因子抑制人肝细胞癌的癌细胞增殖和分裂。
Tumour Biol. 2016 May;37(5):5821-8. doi: 10.1007/s13277-015-4427-6. Epub 2015 Nov 18.
6
MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.微小RNA-451a通过靶向14-3-3ζ抑制肝癌细胞的增殖、转移和上皮-间质转化。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5158-5167. doi: 10.26355/eurrev_201906_18180.
7
LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.LINC00339 通过 miR-152 调控 ROCK1 促进肝癌细胞的增殖和迁移。
J Cell Biochem. 2019 Sep;120(9):14431-14443. doi: 10.1002/jcb.28701. Epub 2019 May 12.
8
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.微小 RNA-101 通过下调 EZH2 并增加细胞抑制性药物敏感性抑制人肝癌进展。
J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.
9
MicroRNA-32 Regulates Development and Progression of Hepatocellular Carcinoma by Targeting ADAMTS9 and Affects Its Prognosis.微小RNA-32通过靶向ADAMTS9调控肝细胞癌的发生发展并影响其预后
Med Sci Monit Basic Res. 2018 Nov 5;24:177-187. doi: 10.12659/MSMBR.910522.
10
Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.慢病毒介导的 microRNA-199a 过表达抑制人肝癌细胞增殖。
Cell Biochem Biophys. 2012 Jan;62(1):237-44. doi: 10.1007/s12013-011-9263-8.

引用本文的文献

1
The epithelial axis is an essential regulator of gut inflammation, energy metabolism, and the microbiome.上皮轴是肠道炎症、能量代谢和微生物组的重要调节者。
Proc Natl Acad Sci U S A. 2024 Jul 2;121(27):e2315944121. doi: 10.1073/pnas.2315944121. Epub 2024 Jun 25.
2
The intervention effect of Aitongxiao prescription on primary liver cancer rats was evaluated based on high-throughput miRNA sequencing and bioinformatics analysis.基于高通量miRNA测序和生物信息学分析,评估了癌痛消方对原发性肝癌大鼠的干预效果。
Front Oncol. 2023 May 29;13:1050069. doi: 10.3389/fonc.2023.1050069. eCollection 2023.
3
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers.微小RNA与JAK/STAT3信号传导:血液系统恶性肿瘤中一个新的有前景的治疗靶点
Genes Dis. 2021 Dec 3;9(4):849-867. doi: 10.1016/j.gendis.2021.10.009. eCollection 2022 Jul.
4
HOXC6 Regulates the Epithelial-Mesenchymal Transition through the TGF-/Smad Signaling Pathway and Predicts a Poor Prognosis in Glioblastoma.HOXC6通过TGF-β/Smad信号通路调控上皮-间质转化并预测胶质母细胞瘤的不良预后。
J Oncol. 2022 May 5;2022:8016102. doi: 10.1155/2022/8016102. eCollection 2022.
5
Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma.HOX家族成员作为肝细胞癌新型诊断和预后标志物的综合分析
J Oncol. 2022 Feb 23;2022:5758601. doi: 10.1155/2022/5758601. eCollection 2022.
6
Downregulation of HOXC6 by miR-27a ameliorates gefitinib resistance in non-small cell lung cancer.miR-27a介导的HOXC6下调改善非小细胞肺癌对吉非替尼的耐药性。
Am J Cancer Res. 2021 Sep 15;11(9):4329-4346. eCollection 2021.
7
MiR-147: Functions and Implications in Inflammation and Diseases.miR-147:在炎症和疾病中的功能及意义。
Microrna. 2021;10(2):91-96. doi: 10.2174/2211536610666210707113605.
8
Long Non-coding RNA LINC00847 Induced by E2F1 Accelerates Non-small Cell Lung Cancer Progression Through Targeting miR-147a/IFITM1 Axis.由E2F1诱导的长链非编码RNA LINC00847通过靶向miR-147a/IFITM1轴加速非小细胞肺癌进展。
Front Med (Lausanne). 2021 Apr 22;8:663558. doi: 10.3389/fmed.2021.663558. eCollection 2021.
9
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent.5-氟尿嘧啶:关于调节机制在导致对这种化疗药物产生耐药性中所起作用的叙述性综述
Front Oncol. 2021 Apr 19;11:658636. doi: 10.3389/fonc.2021.658636. eCollection 2021.
10
Intestinal miRNAs regulated in response to dietary lipids.肠道 microRNA 响应膳食脂质的调节。
Sci Rep. 2020 Nov 3;10(1):18921. doi: 10.1038/s41598-020-75751-w.

本文引用的文献

1
Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.miR-218的过表达通过RET抑制肝癌细胞生长。
Tumour Biol. 2015 Mar;36(3):1511-8. doi: 10.1007/s13277-014-2679-1. Epub 2014 Nov 6.
2
Hepatocellular carcinoma epidemiology.肝细胞癌流行病学
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):753-70. doi: 10.1016/j.bpg.2014.08.007. Epub 2014 Aug 23.
3
Aberrant regulation and function of microRNAs in cancer.微小RNA在癌症中的异常调控与功能
Curr Biol. 2014 Aug 18;24(16):R762-76. doi: 10.1016/j.cub.2014.06.043.
4
HOX genes and their role in the development of human cancers.HOX基因及其在人类癌症发展中的作用。
J Mol Med (Berl). 2014 Aug;92(8):811-23. doi: 10.1007/s00109-014-1181-y. Epub 2014 Jul 5.
5
MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.微小RNA作为食管癌中的癌基因或肿瘤抑制因子:潜在的生物标志物和治疗靶点
Cell Prolif. 2014 Aug;47(4):277-86. doi: 10.1111/cpr.12109. Epub 2014 Jun 6.
6
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.肝细胞癌综述:当前的治疗方法与循证医学
World J Gastroenterol. 2014 Apr 21;20(15):4115-27. doi: 10.3748/wjg.v20.i15.4115.
7
Systemic therapy of hepatocellular carcinoma: current status and future perspectives.肝细胞癌的全身治疗:现状与未来展望。
World J Gastroenterol. 2014 Mar 28;20(12):3087-99. doi: 10.3748/wjg.v20.i12.3087.
8
Hepatocellular carcinoma: clinical frontiers and perspectives.肝细胞癌:临床前沿与展望。
Gut. 2014 May;63(5):844-55. doi: 10.1136/gutjnl-2013-306627. Epub 2014 Feb 14.
9
MicroRNA: function, detection, and bioanalysis.微小RNA:功能、检测与生物分析
Chem Rev. 2013 Aug 14;113(8):6207-33. doi: 10.1021/cr300362f. Epub 2013 May 22.
10
MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.微小RNA发挥肿瘤抑制因子或癌基因的作用:头颈部鳞状细胞癌中微小RNA的异常表达
Auris Nasus Larynx. 2013 Apr;40(2):143-9. doi: 10.1016/j.anl.2012.07.001. Epub 2012 Jul 24.

微小RNA-147通过抑制HOXC6抑制人肝癌细胞的增殖、迁移和化疗敏感性。

MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

作者信息

Sui Cheng-Jun, Xu Feng, Shen Wei-Feng, Dai Bing-Hua, Lu Jiong-Jiong, Zhang Min-Feng, Yang Jia-Mei

机构信息

Department of Special Medical Care and Liver Transplantation, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University Shanghai 200438, China.

出版信息

Am J Cancer Res. 2016 Dec 1;6(12):2787-2798. eCollection 2016.

PMID:28042500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5199754/
Abstract

Patients with hepatocellular carcinoma (HCC) experience poor prognosis and low survival rates. In this study, we explored the molecular mechanism of microRNA-147 (miR-147) in regulating human HCC. We firstly used quantitative RT-PCR (qRT-PCR) to compare the expression levels of miR-147 between 7 HCC and two normal liver cell lines, as well as 10 paired primary HCC tissues and their adjacent non-carcinoma tissues. We found miR-147 was down-regulated in both HCC cell lines and primary HCCs tissues. HCC cell lines HepG2 and HuH7 were transfected with lentiviral vector of miR-147 mimics. We found overexpressing miR-147 significantly inhibited HCC proliferation and migration, increased 5-FU chemosensitivity, and reduced tumorigenicity. Luciferase, qRT-PCR and western blot assays showed that HOXC6 was the downstream target of miR-147, and both gene and protein levels of HOXC6 were down-regulated by miR-147 in HCC cells. SiRNA mediated HOXC6 knockdown inhibited proliferation and migration, and increased 5-FU chemosensitivity in HCC. On the other hand, HOXC6 overexpression reversed the inhibitory effect of miR-147 on HCC proliferation. Therefore, our results suggest that miR-147 can modulates HCC development through the regulation on HOXC6.

摘要

肝细胞癌(HCC)患者预后较差,生存率较低。在本研究中,我们探讨了微小RNA - 147(miR - 147)调控人类HCC的分子机制。我们首先使用定量逆转录聚合酶链反应(qRT - PCR)比较了7种HCC细胞系与两种正常肝细胞系之间,以及10对原发性HCC组织及其相邻非癌组织中miR - 147的表达水平。我们发现miR - 147在HCC细胞系和原发性HCC组织中均下调。用miR - 147模拟物的慢病毒载体转染HCC细胞系HepG2和HuH7。我们发现过表达miR - 147可显著抑制HCC增殖和迁移,增加5 - 氟尿嘧啶(5 - FU)化疗敏感性,并降低致瘤性。荧光素酶、qRT - PCR和蛋白质印迹分析表明HOXC6是miR - 147的下游靶标,miR - 147在HCC细胞中可下调HOXC6的基因和蛋白水平。小干扰RNA(SiRNA)介导的HOXC6敲低可抑制HCC增殖和迁移,并增加其对5 - FU的化疗敏感性。另一方面,HOXC6过表达可逆转miR - 147对HCC增殖的抑制作用。因此,我们的结果表明miR - 147可通过调控HOXC6来调节HCC的发展。